Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin revisited.

M J Finkel

    Clinical Therapeutics
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Phenytoin, known for seizure control, shows promise for numerous other conditions based on extensive research. Further studies are underway to confirm its efficacy in various diseases and symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    White-blood-cell monitoring and clozapine.

    Lancet (London, England)·1995
    Same author

    Normal volunteers should not be used for bioavailability or bioequivalence studies of clozapine.

    Pharmaceutical research·1994
    Same author

    Nervous system Lyme borreliosis--revisited [corrected; erratum to be published].

    Archives of neurology·1992
    Same author

    The relationships of the American Society for Clinical Pharmacology and Therapeutics to government.

    Clinical pharmacology and therapeutics·1990
    Same author

    Orphan products development and some methods for maximizing the usefulness of research on rare diseases.

    Progress in clinical and biological research·1985
    Same author

    Adoption of orphan products by the pharmaceutical industry.

    The New England journal of medicine·1984
    Same journal

    Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

    Clinical therapeutics·2026
    Same journal

    Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

    Clinical therapeutics·2026
    Same journal

    Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

    Clinical therapeutics·2026
    Same journal

    Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

    Clinical therapeutics·2026
    Same journal

    Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

    Clinical therapeutics·2026
    Same journal

    Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

    Clinical therapeutics·2026
    See all related articles

    Area of Science:

    • Pharmacology and Neurology
    • Drug repurposing and clinical applications

    Background:

    • Phenytoin is primarily indicated for seizure management in the US.
    • Over 8,000 papers document phenytoin's effects, suggesting utility in ~100 conditions.
    • An FDA advisory committee recommended adding cardiac arrhythmias to its labeling.

    Purpose of the Study:

    • To review existing literature on phenytoin's non-anticonvulsant applications.
    • To assess the evidence for expanding phenytoin's approved indications.
    • To guide future clinical trial investigations for potential new uses.

    Main Methods:

    • An in-depth review of published scientific literature.
    • Analysis of controlled studies and clinical reports.
    • Evaluation of animal studies for potential therapeutic targets.

    Related Experiment Videos

    Main Results:

    • Phenytoin is likely effective for continuous muscle fiber activity syndrome, myotonic muscular dystrophy, and myotonia congenita based on controlled studies.
    • Potential utility observed in epidermolysis bullosa, intermittent explosive disorder, anxiety with anger/irritability, burns, and skin ulcers.
    • Animal studies suggest trials are warranted for cerebral ischemia, stroke, spinal cord injury, angina pectoris, and poor fracture healing.

    Conclusions:

    • Phenytoin demonstrates potential beyond seizure control, supported by substantial literature.
    • Further clinical trials are necessary to confirm efficacy for newly identified conditions.
    • Labeling changes will depend on the outcomes of ongoing and planned studies.